ElevateBio
ElevateBio specializes in cell and gene therapy innovation, offering comprehensive capabilities for the development and commercialization of genetic medicines.
Overview of ElevateBio
ElevateBio is a biotechnology company that focuses on advancing cell and gene therapy innovations. The company is dedicated to offering end-to-end capabilities for the development and commercialization of genetic medicines. They provide comprehensive services in cGMP manufacturing, automation, process development, analytical services, and quality assurance to ensure the efficacy and safety of their therapies.
Technological Platforms at ElevateBio
ElevateBio operates multiple technology platforms essential for the advancement of cell and gene therapies. These include gene editing, cell therapy enabling technologies, and RNA, protein, and vector engineering. These platforms support the development of both ex vivo and in vivo therapies, facilitating the creation of novel treatment options for a variety of genetic conditions.
Partnerships and Collaborations
ElevateBio actively partners with industry and academic institutions to accelerate the development of cell and gene therapies. These collaborations are instrumental in furthering research and bringing innovative treatments to market more efficiently. Through strategic partnerships, ElevateBio leverages external expertise and resources to enhance its capabilities and drive the biotech industry forward.
BaseCamp Facility
The BaseCamp facility in Waltham, Massachusetts, serves as the central hub for ElevateBio's manufacturing and process development activities. This state-of-the-art facility supports the company's operational needs, from cGMP manufacturing to the development of new therapeutic processes. BaseCamp plays a critical role in ensuring the scalability and quality of the therapies developed by ElevateBio.
Funding and Financial Growth
In a significant boost to its growth trajectory, ElevateBio raised $401 million in Series D financing. This capital infusion is intended to accelerate the company's expansion and support the advancement of its diverse pipeline of cell and gene therapies. With these funds, ElevateBio aims to enhance its technological platforms and manufacturing capabilities, furthering its mission to bring innovative genetic medicines to patients.